Found: 9
Select item for more details and to access through your institution.
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
- By:
- Publication type:
- Article
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon‐like peptide‐1 receptor agonist use.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 407, doi. 10.1111/dom.14883
- By:
- Publication type:
- Article
Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUS.
- Published in:
- EP: Europace, 2024, v. 26, n. 7, p. 1, doi. 10.1093/europace/euae183
- By:
- Publication type:
- Article
Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real‐world prospective study.
- Published in:
- Clinical Cardiology, 2020, v. 43, n. 12, p. 1405, doi. 10.1002/clc.23452
- By:
- Publication type:
- Article
XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America.
- Published in:
- Egyptian Heart Journal, 2018, v. 70, n. 4, p. 307, doi. 10.1016/j.ehj.2018.09.002
- By:
- Publication type:
- Article
Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 10, p. e2236123, doi. 10.1001/jamanetworkopen.2022.36123
- By:
- Publication type:
- Article